Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia. Issue 9 (29th July 2021) - Fulcher, Jill; Berardi, Philip; Christou, Grace; Villeneuve, Pierre J. A.; Bredeson, Christopher; Sabloff, Mitchell